Abiopharma

News list

D'Amico Andrew 🟡 adjusted position in 754 shares (1 derivative) of VICOR CORP (VICR) at $330.00 Transaction Date: Jun 23, 2026 | Filing ID: 000014

Full text

News bot June 24, 2026, 5:42 p.m.
🔍 D'Amico Andrew (Executive)

Company: VICOR CORP (VICR)

Report Date: 2026-06-23
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 754
- Total shares sold: 1,508
Detailed Transactions and Holdings:
- Acquired 754 shares of Common Stock at $53.07 per share (Direct)
  Date: 2026-06-23 | Code: M | equity_swap_involved: false | shares_owned_after: 754.00 | transaction_form_type: 4
- Sold 754 shares of Common Stock at $330.0 per share (Direct)
  Date: 2026-06-23 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
- Sold 754 shares of Non Qualified Stock Option at $53.07 per share (Derivative)
  Date: 2026-06-23 | Code: M | Expires: 2033-06-23 | Exercise: 2026-06-23 | equity_swap_involved: false | shares_owned_after: 1,507.00 | transaction_form_type: 4
Footnotes:
- F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.